Bio-Rad Laboratories Inc. logo

Bio-Rad Laboratories Inc. (BUWA)

Market Closed
8 Dec, 20:00
XBER XBER
270. 60
-2.1
-0.77%
9.88B Market Cap
- P/E Ratio
0% Div Yield
0 Volume
11.51 Eps
272.7
Previous Close
Day Range
270.6 270.6
Year Range
187.6 348.9
Want to track BUWA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 66 days

Summary

BUWA closed today lower at €270.6, a decrease of 0.77% from yesterday's close, completing a monthly decrease of -1.49% or €4.1. Over the past 12 months, BUWA stock lost -14.15%.
BUWA is not paying dividends to its shareholders.
The last earnings report, released on Oct 29, 2025, missed the consensus estimates by -1.93%. On average, the company has fell short of earnings expectations by -0.64%, based on the last three reports. The next scheduled earnings report is due on Feb 12, 2026.
Bio-Rad Laboratories Inc. has completed 5 stock splits, with the recent split occurring on Mar 08, 2002.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).

BUWA Chart

Similar

FDY
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
0.32
0%
WSG
China Traditional Chinese Medicine Holdings Co. Ltd.
0.25
-0.78%
Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls

Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls

BIO's Q3 earnings fall short of estimates despite higher revenues, as margin pressure and weak research demand weigh on results.

Zacks | 1 month ago
Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call Transcript

Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call Transcript

Bio-Rad Laboratories, Inc. ( BIO ) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT Company Participants Yong Chung - Vice President of Investor Relations Jonathan DiVincenzo - President & COO Roop Lakkaraju - Executive VP & CFO Norman Schwartz - Chairman & CEO Conference Call Participants Patrick Donnelly - Citigroup Inc., Research Division Daniel Leonard - UBS Investment Bank, Research Division Brandon Couillard - Wells Fargo Securities, LLC, Research Division Tycho Peterson - Jefferies LLC, Research Division Jack Meehan - Nephron Research LLC Presentation Operator Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.

Seekingalpha | 1 month ago
Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 month ago

Bio-Rad Laboratories Inc. (BUWA) FAQ

What is the stock price today?

The current price is €270.60.

On which exchange is it traded?

Bio-Rad Laboratories Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is BUWA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 9.88B.

What is the earnings per share?

The EPS is 2.75.

When is the next earnings date?

The next earnings report will release on Feb 12, 2026.

Has Bio-Rad Laboratories Inc. ever had a stock split?

Bio-Rad Laboratories Inc. had 5 splits and the recent split was on Mar 08, 2002.

Bio-Rad Laboratories Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Norman D. Schwartz CEO
XBER Exchange
US0905722072 ISIN
US Country
7,700 Employees
- Last Dividend
8 Mar 2002 Last Split
- IPO Date

Overview

Bio-Rad Laboratories, Inc., founded in 1952 and based in Hercules, California, is a prominent provider of life science research and clinical diagnostic products globally, serving customers in the United States, Europe, Asia, Canada, and Latin America. The company operates in two key segments: Life Science and Clinical Diagnostics. With a strong commitment to innovation and quality, Bio-Rad develops, manufactures, and distributes a wide range of instruments, systems, reagents, and consumables designed to advance scientific understanding and improve healthcare outcomes. The firm distributes its offerings through a direct sales force, alongside a network of distributors, agents, brokers, and resellers, ensuring broad and effective market reach.

Products and Services

Bio-Rad Laboratories, Inc. offers a vast array of products and services tailored to meet the needs of various markets, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety, as well as clinical diagnostics.

  • Life Science Research Products:

    These include instruments, systems, reagents, and consumables for the separation, purification, characterization, and quantitation of biological materials like cells, proteins, and nucleic acids. These products support critical research areas in proteomics and genomics, empowering scientists to make groundbreaking discoveries in biology and medicine.

  • Clinical Diagnostics Products:

    Bio-Rad offers an extensive range of test systems, informatics systems, test kits, and specialized quality controls. These are designed for application in various settings including hospitals, diagnostic reference labs, transfusion services, and physician office laboratories. The clinical diagnostics segment focuses on providing accurate and reliable tools for the diagnoses of diseases and the monitoring of treatment efficacy.

  • Biopharmaceutical Production Supplies:

    This range supports the production of biopharmaceuticals with a focus on the purification and analysis of biological materials. Bio-Rad's products in this category are essential for ensuring the safety and efficacy of biopharmaceuticals, including vaccines, antibodies, and therapeutic proteins.

  • Food Safety Testing Products:

    Bio-Rad also provides robust solutions for testing the safety of food products. These include reagents, instruments, and systems that help detect potentially harmful contaminants in food, ensuring compliance with international food safety standards and protecting public health.

Contact Information

Address: 1000 Alfred Nobel Drive
Phone: 510 724 7000